Terumo Develops Third-Generation LVAD As Thoratec Builds HeartMate Family
This article was originally published in The Gray Sheet
Executive Summary
New rotary-flow and centrifugal-flow ventricular assist devices are unlikely to ever completely displace pulsatile-flow designs from the LVAD market, Thoratec maintains
You may also be interested in...
MicroMed DeBakey Heart-Assist Device Pivotal Trial Gets IDE Clearance
The pivotal study for MicroMed's DeBakey left-ventricular assist device will be led by Columbia University's Eric Rose, MD, the researcher who helped secure the first FDA approval and Medicare reimbursement of permanent LVADs
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.